Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 20643264)

1.

Stress-related receptor targets for cocaine addiction.

Self DW.

Biol Psychiatry. 2010 Aug 1;68(3):217-8. doi: 10.1016/j.biopsych.2010.06.006. No abstract available.

PMID:
20643264
2.

Glutamate: the new frontier in pharmacotherapy for cocaine addiction.

Uys JD, LaLumiere RT.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):482-91. Review.

PMID:
19128205
3.

Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease.

Benarroch EE.

Neurology. 2008 Mar 18;70(12):964-8. doi: 10.1212/01.wnl.0000306315.03021.2a. Review. No abstract available.

PMID:
18347319
4.

Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction.

Schmidt HD, Pierce RC.

Ann N Y Acad Sci. 2010 Feb;1187:35-75. doi: 10.1111/j.1749-6632.2009.05144.x. Review.

PMID:
20201846
5.

Addictions and stress: clues for cocaine pharmacotherapies.

Picetti R, Schlussman SD, Zhou Y, Ray B, Ducat E, Yuferov V, Kreek MJ.

Curr Pharm Des. 2013;19(40):7065-80. Review.

PMID:
23574443
6.

Targeting of metabotropic glutamate receptors for the treatment of schizophrenia.

Chaki S, Hikichi H.

Curr Pharm Des. 2011;17(2):94-102. Review.

PMID:
21355835
7.

The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?

Pitsikas N.

Eur J Pharmacol. 2014 Jan 15;723:181-4. doi: 10.1016/j.ejphar.2013.12.019. Epub 2013 Dec 18. Review.

PMID:
24361306
8.

Using metabotropic glutamate receptors to modulate cocaine's synaptic and behavioral effects: mGluR1 finds a niche.

Loweth JA, Tseng KY, Wolf ME.

Curr Opin Neurobiol. 2013 Aug;23(4):500-6. doi: 10.1016/j.conb.2013.01.009. Epub 2013 Feb 4. Review.

9.

Corticotropin releasing factor and neuroplasticity in cocaine addiction.

Corominas M, Roncero C, Casas M.

Life Sci. 2010 Jan 2;86(1-2):1-9. doi: 10.1016/j.lfs.2009.11.005. Epub 2009 Nov 13. Review.

PMID:
19914260
10.

Neurobiology of cocaine addiction: implications for new pharmacotherapy.

Kalivas PW.

Am J Addict. 2007 Mar-Apr;16(2):71-8. Review.

PMID:
17453607
11.

Glutamatergic neuroplasticity in cocaine addiction.

Uys JD, Reissner KJ.

Prog Mol Biol Transl Sci. 2011;98:367-400. doi: 10.1016/B978-0-12-385506-0.00009-0. Review.

PMID:
21199777
12.
13.

mGluR2 positive allosteric modulators: a patent review (2009 - present).

Trabanco AA, Cid JM.

Expert Opin Ther Pat. 2013 May;23(5):629-47. doi: 10.1517/13543776.2013.777043. Epub 2013 Mar 2. Review.

PMID:
23452205
14.

Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Haile CN, Mahoney JJ 3rd, Newton TF, De La Garza R 2nd.

Pharmacol Ther. 2012 May;134(2):260-77. doi: 10.1016/j.pharmthera.2012.01.010. Epub 2012 Jan 31. Review.

15.

Metabotropic glutamate receptors (mGluRs) and diabetic neuropathy.

Anjaneyulu M, Berent-Spillson A, Russell JW.

Curr Drug Targets. 2008 Jan;9(1):85-93. Review.

PMID:
18220716
16.

Structure of the metabotropic glutamate receptor.

Jingami H, Nakanishi S, Morikawa K.

Curr Opin Neurobiol. 2003 Jun;13(3):271-8. Review.

PMID:
12850210
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk